the in vitro and in vivo antibacterial activities of a new aminoglycoside antibiotic , arbekacin ( hbk ) , against methicillin-cephem-resistant staphylococcus aureus ( mrsa ) were compared with those of gentamicin ( gm ) , netilmicin ( ntl ) and amikacin ( amk ) .
C0279516
antibacterial
C0002499
amikacin